LIXTE BIOTECHNOLOGY HOLDINGS, INC.|4Jul 8, 9:33 PM ET

Forman Stephen J. 4

4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Jul 8, 2025

Insider Transaction Report

Form 4

Period: 2025-06-30

LIXTE BIOTECHNOLOGY HOLDINGS, INC.LIXT

Forman Stephen J.

Director

Transactions

Award
Options to Purchase Common Stock
2025-06-30+7,754→ 7,754 total
Exercise: $0.91From: 2025-06-30Exp: 2030-06-30→ Common (7,754 underlying)
Award
Options to Purchase Common Stock
2025-06-30+10,000→ 10,000 total
Exercise: $0.91From: 2025-09-30Exp: 2030-06-30→ Common (10,000 underlying)

Holdings

Options to Purchase Common Stock
Exercise: $1.21From: 2025-03-31Exp: 2030-03-31→ Common (5,851 underlying)
5,851
Options to Purchase Common Stock
Exercise: $1.30From: 2024-09-30Exp: 2029-09-30→ Common (3,858 underlying)
3,858
Options to Purchase Common Stock
Exercise: $9.00From: 2017-10-16Exp: 2022-10-16→ Common (833 underlying)
833
Options to Purchase Common Stock
Exercise: $66.00From: 2019-05-22Exp: 2024-05-22→ Common (833 underlying)
833
Options to Purchase Common Stock
Exercise: $2.37From: 2024-06-30Exp: 2029-06-30→ Common (10,000 underlying)
10,000
Options to Purchase Common Stock
Exercise: $2.37From: 2024-06-30Exp: 2029-06-30→ Common (3,018 underlying)
3,018
Warrants to Purchase Common Stock
(indirect: By Trust)
Exercise: $57.00From: 2018-12-07Exp: 2022-12-07→ Common (2,105 underlying)
2,105
Warrants to Purchase Common Stock
(indirect: By Trust)
Exercise: $60.00From: 2018-12-07Exp: 2022-12-07→ Common (1,667 underlying)
1,667
Options to Purchase Common Stock
Exercise: $2.33From: 2025-01-20Exp: 2030-01-20→ Common (3,030 underlying)
3,030
Options to Purchase Common Stock
Exercise: $5.88From: 2023-06-30Exp: 2028-06-30→ Common (10,000 underlying)
10,000
Options to Purchase Common Stock
Exercise: $7.45From: 2022-06-30Exp: 2027-06-30→ Common (10,000 underlying)
10,000
Options to Purchase Common Stock
Exercise: $30.30From: 2021-06-30Exp: 2026-06-30→ Common (10,000 underlying)
10,000
Options to Purchase Common Stock
Exercise: $32.10From: 2021-01-06Exp: 2026-01-06→ Common (5,000 underlying)
5,000

Footnotes (2)

[F1]Effective June 30, 2025, the reporting person was granted stock options to purchase an aggregate of 10,000 shares vesting in eight equal installments on the last day of each subsequent quarter until fully vested with vesting to start on September 30, 2025.
[F2]Effective June 30, 2025 the reporting person was granted stock options in aggregate of 7,754 shares vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan.

Documents

1 file

4
ownership.xmlPrimary